HIV-1C env and gag Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana

Viruses. 2020 Dec 7;12(12):1404. doi: 10.3390/v12121404.

Abstract

HIV-1 compartmentalization in reservoir sites remains a barrier to complete HIV eradication. It is unclear whether there is variation in HIV-1 env and gag between cerebrospinal fluid (CSF) and plasma of individuals with HIV-associated cryptococcal meningitis (CM). We compared HIV-1 env characteristics and the gag cytotoxic T-lymphocyte (CTL) escape mutations from CSF and plasma samples. Employing population-based Sanger sequencing, we sequenced HIV-1 env from CSF of 25 patients and plasma of 26 patients. For gag, 15 CSF and 21 plasma samples were successfully sequenced. Of these, 18 and 9 were paired env and gag CSF/plasma samples, respectively. There was no statistically significant difference in the proportion of CCR5-using strains in the CSF and plasma, (p = 0.50). Discordant CSF/plasma virus co-receptor use was found in 2/18 pairs (11.1%). The polymorphisms in the HIV-1 V3 loop were concordant between the two compartments. From the HIV-1 gag sequences, three pairs had discordant CTL escape mutations in three different epitopes of the nine analyzed. These findings suggest little variation in the HIV-1 env between plasma and CSF and that the CCR5-using strains predominate in both compartments. HIV-1 gag CTL escape mutations also displayed little variation in CSF and plasma suggesting similar CTL selective pressure.

Keywords: Botswana; CCR5; CXCR4; cerebrospinal fluid; co-receptor; cryptococcal meningitis; escape mutations; human immunodeficiency virus (HIV); plasma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / blood
  • AIDS-Related Opportunistic Infections / cerebrospinal fluid
  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / metabolism*
  • Adult
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Botswana
  • CD4 Lymphocyte Count
  • Cross-Sectional Studies
  • Disease Susceptibility
  • Female
  • HIV Infections / complications*
  • HIV Infections / virology
  • Humans
  • Immunocompromised Host
  • Male
  • Meningitis, Cryptococcal / blood
  • Meningitis, Cryptococcal / cerebrospinal fluid
  • Meningitis, Cryptococcal / etiology*
  • Meningitis, Cryptococcal / metabolism*
  • Middle Aged
  • Mutation
  • RNA, Viral
  • Viral Load
  • env Gene Products, Human Immunodeficiency Virus / blood
  • env Gene Products, Human Immunodeficiency Virus / cerebrospinal fluid
  • env Gene Products, Human Immunodeficiency Virus / metabolism*
  • gag Gene Products, Human Immunodeficiency Virus / blood
  • gag Gene Products, Human Immunodeficiency Virus / cerebrospinal fluid
  • gag Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • RNA, Viral
  • env Gene Products, Human Immunodeficiency Virus
  • gag Gene Products, Human Immunodeficiency Virus